Santiago Barrio

Majadahonda, MD 28222, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications

Exploratory Study to Evaluate the Impact of Interim PET/CT Assessment in First-Line Follicular Lymphoma.

Exploratory Study to Evaluate the Impact of Interim PET/CT Assessment in First-Line Follicular Lymphoma.

Journal: Cancers
Published: January 15, 2025

A large-scale database of T-cell receptor beta sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.

A large-scale database of T-cell receptor beta sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.

Journal: Frontiers in immunology
Published: August 30, 2024

Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels.

Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels.

Journal: Frontiers in immunology
Published: August 30, 2024

Extracellular Vesicle DNA Extraction and Sequencing in Ancient Serum Samples From Patients With Breast Cancer.

Extracellular Vesicle DNA Extraction and Sequencing in Ancient Serum Samples From Patients With Breast Cancer.

Journal: Anticancer research
Published: May 09, 2024

Author Correction: Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA.

Author Correction: Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA.

Journal: Scientific reports
Published: March 29, 2024

Measurable residual disease (MRD) dynamics in multiple myeloma and the influence of clonal diversity analyzed by artificial intelligence.

Measurable residual disease (MRD) dynamics in multiple myeloma and the influence of clonal diversity analyzed by artificial intelligence.

Journal: Blood cancer journal
Published: March 22, 2024

Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.

Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.

Journal: Frontiers in immunology
Published: December 04, 2023

Clonal competition assays identify fitness signatures in cancer progression and resistance in multiple myeloma.

Clonal competition assays identify fitness signatures in cancer progression and resistance in multiple myeloma.

Journal: HemaSphere
Published: November 19, 2023

Genetic Profiling of Cell-Free DNA in Liquid Biopsies: A Complementary Tool for the Diagnosis of B-Cell Lymphomas and the Surveillance of Measurable Residual Disease.

Genetic Profiling of Cell-Free DNA in Liquid Biopsies: A Complementary Tool for the Diagnosis of B-Cell Lymphomas and the Surveillance of Measurable Residual Disease.

Journal: Cancers
Published: July 07, 2023

Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges.

Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges.

Journal: Frontiers in immunology
Published: July 03, 2023

Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma.

Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma.

Journal: Communications biology
Published: July 03, 2023

Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.

Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.

Journal: Frontiers in immunology
Published: June 20, 2023
Showing 1-12 of 46

Last Updated: 09/26/2026